Tapas Das

Tapas Das

Auto-generated profile, based on publicly available information

Tapas Das

Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Applied Radiation and Isotopes
Verified
Journal Article
Closed access
MPM.R.A. Pillai
M.R.A. Pillai
SCSudipta Chakraborty
Sudipta Chakraborty
TDTapas Das
Tapas Das
MVMeera Venkatesh
Meera Venkatesh
NRN. Ramamoorthy
N. Ramamoorthy

1 January 2013 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
TDTapas Das
Tapas Das
MPM.R.A. Pillai
M.R.A. Pillai

23 November 2015 in Current Radiopharmaceuticals
Verified
Journal Article
Closed access
TDTapas Das
Tapas Das
SBSharmila Banerjee
Sharmila Banerjee
Lutetium-177 has been widely discussed as a radioisotope of choice for targeted radionuclide therapy. The simultaneous emission of imageable gamma photons [208 keV (11%) and 113 keV (6.4%)] along with particulate β- emission [β(max) = 497 keV] makes it a theranostically desirable radioisotope. In the present article, the possibility of using two 177Lu-based agents viz. 177Lu-EDTMP and 177Lu-DOTATATE for theranostic applications in metastatic bone pain palliation (MBPP) and peptide receptor radionuclide therapy (PRRT), have been explored. In the case of 177Lu-EDTMP, the whole-body images obtained are compared with those recorded using 99mTc-MDP in the same patient. On the other hand, pre-therapy images acquired with 177Lu-DOTA-TATE are compared with similar images obtained with standard agents, such as 99mTc-HYNIC-TOC (SPECT) and 68Ga-DOTA-TOC (PET) in the same patient. The advantage of the long physical half-life (T1/2) of 177Lu has been utilized in mapping the pharmacokinetics of two additional agents, 177Lu-labeled hydroxyapatite (HA) in radiation synovectomy of knee joints and 177Lu-HA for therapy of hepatocellular carcinoma. Results of these multiple studies conclusively document the potential of 177Lu as a theranostic radioisotope

1 September 2008 in Applied Radiation and Isotopes
Verified
Journal Article
Closed access
SCSudipta Chakraborty
Sudipta Chakraborty
TDTapas Das
Tapas Das
HSHaladhar Dev Sarma
Haladhar Dev Sarma
MVMeera Venkatesh
Meera Venkatesh
SBSharmila Banerjee
Sharmila Banerjee

1 October 2010 in Nuclear Medicine and Biology
Verified
Journal Article
Closed access
RCRubel Chakravarty
Rubel Chakravarty
TDTapas Das
Tapas Das
ADAshutosh Dash
Ashutosh Dash
MVMeera Venkatesh
Meera Venkatesh

1 August 2002 in Applied Radiation and Isotopes
Verified
Journal Article
Closed access
TDTapas Das
Tapas Das
SCSudipta Chakraborty
Sudipta Chakraborty
PUP.R Unni
P.R Unni
SBSharmila Banerjee
Sharmila Banerjee
GSGrace Samuel
Grace Samuel
MPM.R.A Pillai
M.R.A Pillai